Clinical trials of immunomodulatory therapies in severe sepsis and septic shock

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Jean-Louis VincentMarc-Jacques Dubois

Abstract

Sepsis remains one of the leading causes of mortality in critically ill patients. Increased insight into the complexities of this disease process has resulted in the targeting of various aspects of the inflammatory response as offering potential therapeutic benefits. There have been encouraging results in the past few years. Some of the tested agents have been shown to improve mortality rates in large randomized controlled trials involving patients with severe sepsis. In this article, we discuss the positive and negative results of trials in this field; some of the possible reasons for the negative results are examined, and directions for the future are suggested.

References

Sep 1, 1976·Annals of Surgery·W Schumer
Sep 30, 1991·The American Journal of Medicine·G R Bernard
Nov 1, 1991·The American Review of Respiratory Disease·G R BernardJ J Vrbanac
Aug 1, 1989·The Journal of Clinical Investigation·J H NuijensC E Hack
Sep 10, 1987·The New England Journal of Medicine·UNKNOWN Veterans Administration Systemic Sepsis Cooperative Study Group
Jan 12, 1984·The New England Journal of Medicine·S L HoffmanA A Loedin
Nov 11, 1982·The New England Journal of Medicine·E J ZieglerA I Braude
Jul 1, 1995·Antimicrobial Agents and Chemotherapy·S E BucklinD C Morrison
Jan 1, 1994·Cardiovascular Research·A PetrosP Vallance
Feb 1, 1995·Critical Care Medicine·J C PreiserJ L Vincent
Jul 1, 1995·Critical Care Medicine·R Lefering, E A Neugebauer
Aug 1, 1995·Critical Care Medicine·C R Daemen-GubbelsL G Thijs
Apr 1, 1995·The Journal of Pediatrics·G E RivardH P Schwarz
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·D F EiermanA S Janoff
Feb 1, 1995·Critical Care Medicine·J Gómez-JiménezS Moncada
Aug 1, 1994·Journal of the American Society of Nephrology : JASN·S Goldfarb, T A Golper
Jun 1, 1994·Circulation Research·J F KeaneyJ Loscalzo
Sep 1, 1993·Critical Care Medicine·J A LorenteD Liste

❮ Previous
Next ❯

Citations

Nov 9, 2011·Irish Journal of Medical Science·T C HallA R Dennison
Aug 14, 2012·Current Infectious Disease Reports·Susanne Toussaint, Herwig Gerlach
May 17, 2003·Clinical Therapeutics·Christopher McCoy, Samuel James Matthews
Oct 3, 2002·Nature Medicine·Niels C Riedemann, Peter A Ward
Mar 26, 2004·Nature Reviews. Immunology·Peter A Ward
Nov 24, 2004·The Journal of Experimental Medicine·Sébastien GibotGilbert C Faure
May 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Evangelos J Giamarellos-BourboulisHelen Giamarellou
Jan 28, 2003·Dimensions of Critical Care Nursing : DCCN·Christine Smith Schulman, Kathy Hare
Oct 3, 2002·Current Opinion in Critical Care·Curtis N Sessler, Wes Shepherd
Feb 6, 2004·Critical Care Medicine·Mark T Lin, Timothy E Albertson
Jul 20, 2004·Current Opinion in Critical Care·John C Marshall
Sep 24, 2004·Current Opinion in Critical Care·Scott D Imahara, Grant E O'Keefe
Apr 29, 2005·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Steven M Opal
Mar 20, 2009·Shock·Fabio Silvio TacconeJean-Louis Vincent
Dec 22, 2010·Infection and Immunity·Gabriela BarreraGabriela C Fernández
Feb 1, 2003·BMJ : British Medical Journal·Pierre-Yves Bochud, Thierry Calandra
Apr 4, 2008·Mediators of Inflammation·Magdalini KyriakopoulouEvangelos J Giamarellos-Bourboulis
Nov 5, 2011·BMC Infectious Diseases·Thekla PoukoulidouUNKNOWN Hellenic Sepsis Study Group
Jun 28, 2005·BMC Infectious Diseases·Evangelos J Giamarellos-BourboulisHelen Giamarellou
Feb 8, 2005·Critical Care : the Official Journal of the Critical Care Forum·Nils G MorgenthalerBeat Müller
May 16, 2006·Critical Care : the Official Journal of the Critical Care Forum·Evangelos J Giamarellos-BourboulisHelen Giamarellou
Nov 30, 2006·Critical Care : the Official Journal of the Critical Care Forum·Evangelos J Giamarellos-BourboulisHelen Giamarellou
May 28, 2010·Critical Care : the Official Journal of the Critical Care Forum·Charalambos GogosEvangelos J Giamarellos-Bourboulis
Jan 20, 2011·Critical Care : the Official Journal of the Critical Care Forum·Evangelos J Giamarellos-BourboulisMihai G Netea
Jul 25, 2008·Future Microbiology·Jonathan A McCullers, B Keith English
Dec 23, 2010·Immunotherapy·Anastasia Antonopoulou, Evangelos J Giamarellos-Bourboulis
Nov 3, 2009·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Anil T KumarMedha Y Rao
Jan 1, 2008·The Libyan Journal of Medicine·Bredan As, Cauwels A
Oct 19, 2010·Clinical & Developmental Immunology·Briana Leung, Hobart W Harris
Mar 1, 2013·Immunotherapy·Evangelos J Giamarellos-Bourboulis
Dec 5, 2012·EMBO Molecular Medicine·Peter A Ward
Jan 28, 2012·Clinica Chimica Acta; International Journal of Clinical Chemistry·Yan-Qiang HouSunghee Kim
Nov 27, 2014·Journal of Anaesthesiology, Clinical Pharmacology·Ashish K Khanna, Krzysztof Laudanski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.